Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion

Contributed by: Business Wire

Logo

Images

Dr. Yooni Kim, Managing Director APAC, Novotech (Photo: Business Wire)

Business Wire embedded0

Tags

Science

Biotechnology

Research

Pharmaceutical

Health

Consulting

Professional Services

Clinical Trials

Dr. Yooni Kim

More Like This

Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025

Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19.

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration